Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Blood-based biomarkers of tumor sensitivity to PD-1 antagonists

Blood-based biomarkers of tumor sensitivity to PD-1 antagonists

US Patent 11326211 · Granted May 10, 2022

Estimated economic value: $318,775,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

System and methods for deriving gene signature biomarkers of response to PD-1 an2022
System and methods for deriving gene signature biomarkers of response to PD-1 an2022
System and methods for deriving gene signature biomarkers of response to PD-1 an2022
System and methods for deriving gene signature biomarkers of response to PD-1 an2022
System and methods for deriving gene signature biomarkers of response to PD-1 an2022
Gene signatures for determining ICOS expression2021
Immune gene signatures in treating breast cancer2020
Reloadable magazine apparatus configured to accept a plurality of cartridges2019
Immune gene signatures in cancer2018
Immune gene signatures in cancer2018
Biomarkers for TSLP treatment2017
Immune gene signatures in cancer2016